The first modified adeno-associated virus was recently approved for clinical gene therapy in the Western world. Scientists say it appears that no cancer risk emanates from the virus used for gene delivery.
The first modified adeno-associated virus was recently approved for clinical gene therapy in the Western world. Scientists say it appears that no cancer risk emanates from the virus used for gene delivery.